Thomas F. Baumert, MD

Company: Alentis Therapeutics

Job title: Founder

Seminars:

Patient-derived Tumor Spheroids to Model the Tumour Microenvironment & Accelerate Drug Development 10:00 am

Applying patient-derived tumour spheroids to model the tumour immune microenvironment including T cell infiltration and function, tumour fibrosis, CAF and endothelial cell biology Modelling the specific treatment response of compounds on the patient tumour immune environment and cancer epithelial cells using single cell RNASeq and proteomics Understanding how patient-derived tumour spheroids accelerate drug development using…Read more

day: Conference Day Two